Aethlon Medical (AEMD) News Today → Gold Mania (From Stansberry Research) (Ad) Free AEMD Stock Alerts $1.39 +0.02 (+1.46%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.comamericanbankingnews.com - April 28 at 2:20 AMAethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Updateamericanbankingnews.com - April 27 at 3:18 AMAethlon Medical Incmoney.usnews.com - March 25 at 7:43 PMAnalysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)markets.businessinsider.com - March 4 at 12:58 PMAethlon Medical Inc (AEMD)investing.com - March 2 at 11:45 PMAethlon Medical, Inc.: Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devicesfinanznachrichten.de - February 21 at 4:28 PMAethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devicesmarkets.businessinsider.com - February 21 at 4:28 PMAethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devicesfinance.yahoo.com - February 21 at 8:55 AMAethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devicesprnewswire.com - February 21 at 8:01 AMAethlon Medical, Inc.: Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Updatefinanznachrichten.de - February 18 at 7:42 PMAEMD: Focus on Oncology Studies; In Vitro Binding Study Expected to Advance Clinical Trial Activitiesfinance.yahoo.com - February 15 at 4:10 PMAethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcriptfinance.yahoo.com - February 15 at 10:26 AMAethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - February 14 at 6:44 PMAethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Updateprnewswire.com - February 14 at 4:15 PMAethlon Medical Q3 2024 Earnings Previewmsn.com - February 13 at 10:31 PMEarnings Preview: Aethlon Medicalbenzinga.com - February 13 at 5:30 PMAethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024finance.yahoo.com - February 7 at 3:17 PMMaxim Group Keeps Their Hold Rating on Aethlon Medical (AEMD)markets.businessinsider.com - November 18 at 3:53 AMAEMD: Expect Focus on Oncology Studies; Cost Containment Effortsfinance.yahoo.com - November 16 at 5:24 PMAethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcriptfinance.yahoo.com - November 16 at 12:24 PMAethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 9:17 PMA Preview Of Aethlon Medical's Earningsbenzinga.com - November 13 at 12:10 PMAethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officerfinance.yahoo.com - November 13 at 12:10 PMAethlon Medical Inc AEMDmorningstar.com - November 11 at 8:12 AMAethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023finance.yahoo.com - November 6 at 11:16 AMAethlon Medical (AEMD) Price Target Increased by 900.00% to 66.30msn.com - November 1 at 9:18 AMPromising Oncology Developments and Positive Outlook Propel Aethlon Medical’s Buy Ratingmarkets.businessinsider.com - October 26 at 1:28 AMHC Wainwright & Co. Maintains Aethlon Medical (AEMD) Buy Recommendationmsn.com - October 25 at 10:26 AMAethlon Medical receives approval in India for Hemopurifier trialmsn.com - October 12 at 7:14 AMAethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncologyfinance.yahoo.com - October 10 at 9:06 AMAethlon Medical, Inc.: Aethlon Announces Reverse Stock Splitfinanznachrichten.de - October 5 at 2:27 PMAethlon Medical to effect 1-for-10 reverse stock split to meet Nasdaq rulesseekingalpha.com - October 5 at 9:25 AMAethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - August 30 at 2:31 PMMaxim Group Sticks to Its Hold Rating for Aethlon Medical (AEMD)markets.businessinsider.com - August 15 at 9:00 PMAEMD: Focusing on Oncology, Infectious Disease & Organ Transplants Initiallyfinance.yahoo.com - August 14 at 2:03 PMAethlon Medical, Inc.: Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Updatefinanznachrichten.de - August 11 at 4:46 AMAethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - August 10 at 5:41 PMAethlon Medical (AEMD) Price Target Decreased by 7.14% to 6.63msn.com - August 3 at 9:29 PMAethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023finance.yahoo.com - August 3 at 11:57 AMAethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplantfinance.yahoo.com - July 24 at 12:09 PMAethlon Medical (AEMD) Price Target Decreased by 5.15% to 7.14msn.com - July 6 at 11:10 PMAEMD: Expanding Research Efforts & Strengthening Team, While Minimizing R&D Spendingfinance.yahoo.com - July 6 at 6:09 PMAethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directorsfinance.yahoo.com - July 6 at 6:09 PMAethlon Medical, Inc. (NASDAQ:AEMD) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - June 30 at 2:20 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Aethlon Medical (AEMD) and Actinium Pharmaceuticals (ATNM)markets.businessinsider.com - June 30 at 9:18 AMAethlon Medical, Inc.: Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Updatefinanznachrichten.de - June 29 at 8:47 AMAethlon Medical GAAP EPS of -$0.59 beats by $0.04, revenue of $574.24Mmsn.com - June 28 at 7:17 PMAethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023finance.yahoo.com - June 22 at 9:14 AMAethlon evaluating use of Hemopurifier device in organ transplantationmsn.com - June 21 at 6:36 PMAethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantationfinance.yahoo.com - June 21 at 8:35 AM Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. AEMD Media Mentions By Week AEMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEMD News Sentiment▼0.000.42▲Average Medical News Sentiment AEMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEMD Articles This Week▼01▲AEMD Articles Average Week Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: UTRS News INVO News OSA News IONM News STSS News TMDIF News AFIB News NMRD News VERO News TNON News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEMD) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressUrgent Nvidia WarningAltimetryMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.